China Orthopedic Instrument Industry Report, 2014-2017
  • Aug.2014
  • Hard Copy
  • USD $2,450
  • Pages:104
  • Single User License
    (PDF Unprintable)       
  • USD $2,300
  • Code: ZLC007
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,500
  • Hard Copy + Single User License
  • USD $2,650
      

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.

Being optimistic about bright future of China orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China’s largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.

The Chinese orthopedic instrument market now is dominated by Johnson & Johnson, Zimmer, Medtronic, Stryker and other foreign companies, together holding 40%-50% market share. However, local Chinese companies like Shandong Weigao Group Medical Polymer Co. Limited, Shanghai Kinetic Medical Co., Ltd. and United Orthopedic Corporation have made some progress in R&D and production technology in recent years, and grabbed some marker share by virtue of advantages in cost and channel.

Shandong Weigao Group Medical Polymer has become the largest local orthopedics company in China with a market share of 4.3%; Shanghai Kinetic Medical is a leader in vertebroplasty interventional operation system, occupying about 50% of the Chinese percutaneous kyphoplasty (PKP) market; United Orthopedic Corporation is a champion in artificial knee/hip joint with 4%-6% market share in China.

China Orthopedic Instrument Industry Report, 2014-2017 focuses on the following:
20120114.gifDevelopment of the Chinese orthopedic instrument market, including market size, market structure, import & export, competitive landscape, barriers to entry and sales model;
20120114.gifDevelopment environment of the Chinese orthopedic instrument market, covering global market environment, policy environment, macro environment, upstream and downstream sectors and development prospects;
20120114.gifOperation and orthopedic instrument business of 4 foreign and 14 local Chinese orthopedics companies.

骨科器械 英文_副本.jpg

1. Overview of Orthopedic Instrument Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of Global Orthopedic Instrument Industry
2.1 Overview
2.2 Forecast

3. Development of China Orthopedic Instrument Industry
3.1 Overview
3.2 Market Structure
3.3 Import and Export
3.3.1 Import
3.3.2 Export
3.4 Competitive Landscape
3.5 Barriers to Entry
3.5.1 Technology Barrier
3.5.2 Market Access Barrier
3.5.3 Sales Channel Barrier
3.5.4 Talent Barrier
3.6 Sales Model

4. Development Environment of China Orthopedic Instrument Industry
4.1 Policy Environment
4.1.1 Regulatory Policy
4.1.2 Industrial Policy
4.2 Macro Environment
4.3 Upstream and Downstream Industries
4.3.1 Upstream Industry
4.3.2 Downstream Industry
4.4 Prospects

5. Foreign Companies in China
5.1 Johnson & Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Orthopedic Instrument Business
5.1.6 Development in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Orthopedic Instrument Business
5.2.6 Development in China
5.3 Stryker
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Development in China
5.4 Zimmer
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Orthopedic Instrument Business
5.4.6 Development in China

6. Major Chinese Companies
6.1 Shandong Weigao Group Medical Polymer
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 Orthopedic Instrument Business
6.1.6 R&D and Investment
6.1.7 Customers
6.1.8 Forecast and Outlook
6.2 Shanghai Kinetic Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 R&D and Investment
6.2.6 Forecast and Outlook
6.3 United Orthopedic Corporation
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Forecast and Outlook
6.4 Beijing AKEC Medical
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment
6.4.6 Capacity, Output and Sales Volume
6.4.7 Customers and Suppliers
6.5 Suzou Xinrong Best Medical Instrument
6.5.1 Profile
6.5.2 Operation
6.5.3 Orthopedic Instrument Business
6.6 Tianjin Walkman Biomaterial
6.6.1 Profile
6.6.2 Operation
6.6.3 Orthopedic Instrument Business
6.7 Beijing Lidakang Science and Technology
6.7.1 Profile
6.7.2 Operation
6.7.3 Orthopedic Instrument Business
6.8 Tianjin Renli Orthopedic Instrument
6.8.1 Profile
6.8.2 Operation
6.9 Zhejiang Guangci Medical Device
6.9.1 Profile
6.9.2 Orthopedic Instrument Business
6.10 Suzhou AND Science & Technology Development
6.10.1 Profile
6.10.2 Orthopedic Instrument Business
6.11 Beijing Chunlizhengda Technology & Development
6.11.1 Profile
6.11.2 Orthopedic Instrument Business
6.12 Baimtec Material
6.12.1 Profile
6.12.2 Orthopedic Instrument Business
6.13 Suzhou Kangli Orthopedics Instrument
6.13.1 Profile
6.13.2 Orthopedic Instrument Business
6.14 Waston Medical Appliance
6.14.1 Profile
6.14.2 Orthopedic Instrument Business

7. Forecast and Outlook
7.1 Market Size Forecast
7.2 Operation Comparison of Major Companies
7.2.1 Revenue
7.2.2 Net Income
7.2.3 Gross Margin
7.2.4 Orthopedic Instrument Business

Category of Orthopedic Instrument Industry
Orthopedic Instrument Industry Chain 
Global Orthopedic Instrument Market Size and Growth Rate, 2009-2013 
Global Market Share of Orthopedic Instruments by Product, 2013 
Global Orthopedic Instrument Market Size, 2012-2017E
Market Size and Growth Rate of Orthopedic Instrument Industry above Designated Scale in China, 2009-2013
Market Size and Growth Rate of China Orthopedic Instrument Industry, 2009-2013
Market Size of Orthopedic Instruments in China by Product, 2009-2013
Market Share of Orthopedic Instruments in China by Product, 2009-2013
Import Volume and Value of Orthopedic or Fracture Appliances in China, 2009-2014
Top10 Sources of Imported Orthopedic or Fracture Appliances by Import Volume in China, H1 2014
Import Volume and Value of Artificial Joint in China, 2009-2014
Top10 Sources of Imported Artificial Joint in China by Import Volume, H1 2014
Export Volume and Value of Orthopedic or Fracture Appliances from China, 2009-2014
Top10 Destinations of Exported Orthopedic or Fracture Appliances from China by Export Volume, H1 2014
Export Volume and Value of Artificial Joint in China, 2009-2014
Top10 Destinations of Exported Artificial Joint from China by Export Volume, H1 2014
Competitive Landscape of China Orthopedic Instrument Industry, 2013
Chinese Orthopedic Instrument Market Structure by Company, 2013
Market Share of Trauma Instruments in China Orthopedic Instrument Industry, 2013
Market Share of Spine Instruments in China Orthopedic Instrument Industry, 2013
Market Share of Joints in China Orthopedic Instrument Industry, 2013
Application Process for Orthopedic Instrument Products Permit
Sales Process of Orthopedic Instruments in China
Policies and Main Contents Concerning Orthopedic Instrument Industry in China, 2007-2014
Health Costs and % of GDP in China, 1980-2013
Per Capita Health Costs and YoY Growth Rate in China, 2006-2012
Number of People 65 and over and % of Total Population, 2004-2013
Number of Medical Institutions in China, 2012-2013
Medical Service Quantity of Health Care Facilities in China, 2012-2013
Total Revenue and Net Income of Johnson & Johnson, 2009-2014
Total Revenue Breakdown of Johnson & Johnson (by Product), 2009-2014
Total Revenue Structure of Johnson & Johnson (by Product), 2009-2014
Gross Margin of Johnson & Johnson, 2009-2014
Orthopedics Business Revenue and % of Total Revenue of Johnson & Johnson, 2010-2013
Johnson & Johnson’s Companies in China and Main Products
Revenue and Net Income of Medtronic, FY2010- FY2014
Revenue Breakdown of Medtronic (by Product), FY2010- FY2014
Revenue Structure of Medtronic (by Product), FY2010- FY2014
Gross Margin of Medtronic, FY2010- FY2014
Spine Business Revenue and % of Total Revenue of Medtronic, FY2012- FY2014
Revenue and Net Income of Stryker, 2009-2014
Revenue Breakdown of Stryker (by Product), 2009-2014
Revenue Structure of Stryker (by Product), 2009-2014
Reconstructive Business Revenue and Structure of Stryker by Purpose, 2011-2013
MedSurg Business Revenue and Structure of Stryker by Purpose, 2011-2013
Neurotechnology & Spine Business Revenue and Structure of Stryker by Purpose, 2011-2013
Gross Margin of Stryker, 2009-2014
Revenue and Net Income of Trauson Holdings, 2009-2012
Revenue Breakdown of Trauson Holdings (by Product), 2009-2012
Gross Margin of Trauson Holdings, 2009-2012
Output of Main Products of Trauson Holdings, 2008-2011
Capacity Utilization of Main Products of Trauson Holdings, 2008-2011
Revenue and Net Income of Zimmer, 2009-2014
Revenue Breakdown of Zimmer (by Region), 2009-2014
Revenue Structure of Zimmer (by Region), 2009-2014
Revenue Breakdown of Zimmer (by Product), 2009-2014
Revenue Structure of Zimmer (by Product), 2009-2014
Gross Margin of Zimmer, 2009-2014
Zimmer’s Revenue from Reconstructive Products, 2009-2014
Product Varieties and Main Products of Shandong Weigao Group Medical Polymer
Revenue and Net Income of Shandong Weigao Group Medical Polymer, 2009-2014
Revenue Breakdown of Shandong Weigao Group Medical Polymer (by Product), 2009-2013
Revenue Structure of Shandong Weigao Group Medical Polymer (by Product), 2009-2013
Shandong Weigao Group Medical Polymer’s Revenue Breakdown from Single-use Medical Consumables (by Product), 2012-2013
Gross Margin of Shandong Weigao Group Medical Polymer, 2009-2013
Shandong Weigao Group Medical Polymer’s Revenue from Orthopedic Products and YoY Growth, 2009-2013
R&D Costs and % of Total Revenue of Shandong Weigao Group Medical Polymer, 2009-2013
Number of Patents and Registered Certificates of Shandong Weigao Group Medical Polymer, 2007-2013
Number of Customers of Shandong Weigao Group Medical Polymer (by Nature), 2008-2013
Revenue and Net Income of Shandong Weigao Group Medical Polymer, 2012-2017E
Revenue and Net Income of Shanghai Kinetic Medical, 2009-2013
Revenue Breakdown of Shanghai Kinetic Medical (by Region), 2009-2013
Revenue Structure of Shanghai Kinetic Medical (by Region), 2009-2013
Gross Margin of Shanghai Kinetic Medical, 2009-2013
Gross Margin of Shanghai Kinetic Medical (by Region), 2009-2013
Completion Status of R&D Projects of Shanghai Kinetic Medical, 2013
R&D Costs and % of Total Revenue of Shanghai Kinetic Medical, 2011-2013
Business Scope of Shanghai Kinetic Medical, 2013
Revenue and Net Income of Shanghai Kinetic Medical, 2012-2017E
Sales Regions of United Orthopedic
Revenue and Gross Profit of United Orthopedic, 2009-2014
Revenue Breakdown of United Orthopedic (by Region), 2010-2013
Revenue Structure of United Orthopedic (by Product), 2010-2013
Gross Margin of United Orthopedic, 2009-2013
R&D Costs and % of Total Revenue of United Orthopedic, 2009-2014
Revenue and Gross Profit of United Orthopedic, 2012-2017E
Revenue and Net Income of Beijing AKEC Medical, 2009-2011
Revenue Structure of Beijing AKEC Medical (by Product), 2009-2011
Revenue Structure of Beijing AKEC Medical (by Region), 2009-2011
Gross Margin of Beijing AKEC Medical (by Product), 2009-2011
Gross Margin of Main Products of Beijing AKEC Medical, 2009-2011
R&D Costs and % of Total Revenue of Beijing AKEC Medical, 2009-2011
Fundraising Projects of Beijing AKEC Medical, 2012
Capacity, Output and Capacity Utilization of Beijing AKEC Medical, 2009-2011
Output, Sales Volume and Sales/Output Ratio of Beijing AKEC Medical, 2009-2011
Name list and Sales Contribution of Beijing AKEC Medical’s Top 5 Customers, 2009-2011
Name list and Procurement of Beijing AKEC Medical’s Top 5 Suppliers, 2009-2011
Revenue and Total Profit of Suzou Xinrong Best Medical Instrument, 2007-2009
Gross Margin of Suzou Xinrong Best Medical Instrument, 2007-2009
Total Assets and Total Liabilities of Suzou Xinrong Best Medical Instrument, 2007-2009
Suzou Xinrong Best Medical Instrument’s Orthopedic Products by Category
Revenue and Total Profit of Tianjin Walkman Biomaterial, 2007-2009
Gross Margin of Tianjin Walkman Biomaterial, 2007-2009
Total Assets and Total Liabilities of Tianjin Walkman Biomaterial, 2007-2009
Tianjin Walkman Biomaterial’s Orthopedic Instruments by Category
Revenue and Total Profit of Beijing Lidakang Science and Technology, 2007-2009
Gross Margin of Beijing Lidakang Science and Technology, 2007-2009
Total Assets and Total Liabilities of Beijing Lidakang Science and Technology, 2007-2009
Beijing Lidakang Science and Technology’s Orthopedic Instruments by Category
Revenue and Total Profit of Tianjin Renli Orthopedic Instrument, 2007-2009
Gross Margin of Tianjin Renli Orthopedic Instrument, 2007-2009
Total Assets and Total Liabilities of Tianjin Renli Orthopedic Instrument, 2007-2009
Main Orthopedic Instruments of Zhejiang Guangci Medical Device
Suzhou AND Science & Technology Development’s Orthopedic Instruments by Category 
Beijing Chunlizhengda Technology & Development’s Orthopedic Instruments by Category
Waston Medical Appliance’s Orthopedic Instruments by Category
China Orthopedic Instrument Market Size, 2012-2017E
China Orthopedic Instrument Market Size (by Product), 2012-2017E
Market Share of Orthopedic Instruments in China (by Product), 2012-2017E
Revenue Comparison of Major Companies in China Orthopedic Instrument Industry, 2009-2014
Net Income Comparison of Major Companies in China Orthopedic Instrument Industry, 2009-2014
Net Profit Margin Comparison of Major Companies in China Orthopedic Instrument Industry, 2009-2014
Gross Margin Comparison of Major Companies in China Orthopedic Instrument Industry, 2009-2013
Orthopedic Instrument Business Revenue of Major Companies in China Orthopedic Instrument Industry, 2009-2013

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号